Renhua Lu

2.4k total citations · 2 hit papers
61 papers, 1.8k citations indexed

About

Renhua Lu is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Renhua Lu has authored 61 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Nephrology, 11 papers in Cardiology and Cardiovascular Medicine and 7 papers in Molecular Biology. Recurrent topics in Renhua Lu's work include Acute Kidney Injury Research (17 papers), Dialysis and Renal Disease Management (12 papers) and Chronic Kidney Disease and Diabetes (10 papers). Renhua Lu is often cited by papers focused on Acute Kidney Injury Research (17 papers), Dialysis and Renal Disease Management (12 papers) and Chronic Kidney Disease and Diabetes (10 papers). Renhua Lu collaborates with scholars based in China, United States and Italy. Renhua Lu's co-authors include Zhaohui Ni, Leyi Gu, Xinghua Shao, Minfang Zhang, Haijiao Jin, Jianxiao Shen, Qisheng Lin, Wenyan Zhou, Na Jiang and Claudio Ronco and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and Scientific Reports.

In The Last Decade

Renhua Lu

55 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation

2019 498 citations Minfang Zhang, Haijiao Jin et al. profile →
Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy

2020 259 citations Haijiao Jin, Minfang Zhang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Renhua Lu China	19	656	631	486	193	187	61	1.8k
Leyi Gu China	19	594 0.9×	783 1.2×	369 0.8×	72 0.4×	135 0.7×	39	1.6k
Robert Faulhaber‐Walter United States	20	502 0.8×	619 1.0×	193 0.4×	289 1.5×	127 0.7×	32	1.6k
Wei Cao China	21	263 0.4×	602 1.0×	254 0.5×	294 1.5×	146 0.8×	70	1.6k
Hajime Nagasu Japan	19	463 0.7×	668 1.1×	175 0.4×	121 0.6×	174 0.9×	54	1.6k
Isabelle Six France	22	461 0.7×	617 1.0×	281 0.6×	524 2.7×	195 1.0×	48	2.2k
Ling Yu China	20	404 0.6×	420 0.7×	187 0.4×	420 2.2×	217 1.2×	54	1.6k
Sergio Amaro Spain	26	433 0.7×	392 0.6×	1.3k 2.6×	171 0.9×	408 2.2×	79	2.4k
Yani He China	21	626 1.0×	734 1.2×	303 0.6×	66 0.3×	141 0.8×	70	2.0k
Guijun Qin China	24	208 0.3×	553 0.9×	426 0.9×	175 0.9×	73 0.4×	88	1.7k
Wei Su China	22	290 0.4×	446 0.7×	170 0.3×	95 0.5×	208 1.1×	64	1.3k

Countries citing papers authored by Renhua Lu

Since Specialization

Citations

This map shows the geographic impact of Renhua Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renhua Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renhua Lu more than expected).

Fields of papers citing papers by Renhua Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renhua Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renhua Lu. The network helps show where Renhua Lu may publish in the future.

Co-authorship network of co-authors of Renhua Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Renhua Lu. A scholar is included among the top collaborators of Renhua Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renhua Lu. Renhua Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Jiayue, et al.. (2025). Phosphodiesterase 1A overexpression contributes to the progression of renal fibrosis. Molecular Therapy. 34(3). 1539–1553.

Lu, Renhua, et al.. (2025). Effects of Henagliflozin on Cardiac Structure in Patients with Heart Failure with Preserved Ejection Fraction Undergoing Dialysis: The HELD-HF Randomized Controlled Trial. Journal of the American Society of Nephrology. 36(10S). 1 indexed citations

Lu, Renhua, Haijiao Jin, Juan Cao, et al.. (2025). Randomized, Positive-Controlled Study on the Efficacy and Safety of Oral Polysaccharide-Iron Complex Therapy in Patients on Hemodialysis. Kidney International Reports. 10(6). 1742–1749.

Yan, Hao, Wei Wang, Ying Li, et al.. (2024). Effect of henagliflozin on left ventricular mass index in dialysis patients with HFpEF (HELD-HF): protocol for a multicentre, randomised, double-blind, placebo-controlled trial. BMJ Open. 14(8). e087617–e087617. 3 indexed citations

Che, Xiajing, Minfang Zhang, Chaojun Qi, et al.. (2024). The presence of exudative thickening of Bowman’s capsule predict poor prognosis in diabetic kidney disease. Diabetes Research and Clinical Practice. 209. 111594–111594.

Li, Ding, Hao Yan, Zhenyuan Li, et al.. (2023). Pharmacokinetics of Henagliflozin in Dialysis Patients with Diabetes. Clinical Pharmacokinetics. 62(11). 1581–1587. 3 indexed citations

Ni, Zhaohui, Haijiao Jin, Renhua Lu, et al.. (2023). Hyperkalaemia prevalence and dialysis patterns in Chinese patients on haemodialysis: an interim analysis of a prospective cohort study (PRECEDE-K). BMC Nephrology. 24(1). 233–233. 3 indexed citations

Cheng, Qian, et al.. (2023). P2X7R/AKT/mTOR signaling mediates high glucose-induced decrease in podocyte autophagy. Free Radical Biology and Medicine. 204. 337–346. 11 indexed citations

Lu, Renhua, Leyi Gu, Weimin Zhang, et al.. (2021). Protocol for thiamine and folic acid in the treatment of cognitive impairment in maintenance haemodialysis patients: a prospective, randomised, placebo-controlled, double-blind, multicentre study. BMJ Open. 11(12). e050605–e050605. 1 indexed citations

10.

Ni, Zhaohui, Haijiao Jin, Renhua Lu, et al.. (2021). Hyperkalaemia prevalence, recurrence and treatment in patients on haemodialysis in China: protocol for a prospective multicentre cohort study (PRECEDE-K). BMJ Open. 11(12). e055770–e055770. 3 indexed citations

11.

Qian, Yingying, Cheng Qian, Qicheng Fan, et al.. (2021). P2X7 receptor signaling promotes inflammation in renal parenchymal cells suffering from ischemia-reperfusion injury. Cell Death and Disease. 12(1). 132–132. 33 indexed citations

12.

Wei, Yuehan, Dong‐Aolei An, Zhaohui Ni, et al.. (2020). Myocardial Iron Deficiency Quantification and Effective Cardiac Iron Management Strategy Exploration evaluated by Cardiac T2* Mapping in End-Stage Renal Disease Patients. Academic Radiology. 28(4). e101–e109. 2 indexed citations

13.

Che, Miaolin, Bo Xie, Ri‐Tai Huang, et al.. (2019). Use of Both Serum Cystatin C and Creatinine as Diagnostic Criteria for Cardiac Surgery-Associated Acute Kidney Injury and Its Correlation with Long-Term Major Adverse Events. Kidney & Blood Pressure Research. 44(3). 415–425. 5 indexed citations

14.

Cai, Hong, Weiming Zhang, Mingli Zhu, et al.. (2016). Serum phosphorus variation is associated with mortality in maintenance hemodialysis patients. 32(7). 487–493. 1 indexed citations

15.

Sharma, Aashish, José J. Zaragoza, Gianluca Villa, et al.. (2015). Fabry’s disease: an example of cardiorenal syndrome type 5. Heart Failure Reviews. 20(6). 689–708. 11 indexed citations

16.

Zhou, Yijun, et al.. (2015). Plasma Pentraxin 3 Is Closely Associated with Peripheral Arterial Disease in Hemodialysis Patients and Predicts Clinical Outcome: A 6-Year Follow-Up. Blood Purification. 39(4). 266–273. 8 indexed citations

17.

Liu, Shang, Miaolin Che, Song Xue, et al.. (2012). Urinary L-FABP and its combination with urinary NGAL in early diagnosis of acute kidney injury after cardiac surgery in adult patients. Biomarkers. 18(1). 95–101. 53 indexed citations

18.

Zhu, Mingli, Qiang Xia, Siyue Wang, et al.. (2012). Urinary neutrophil gelatinase-associated lipocalin and L-type fatty acid binding protein as diagnostic markers of early acute kidney injury after liver transplantation. Biomarkers. 17(4). 336–342. 29 indexed citations

19.

Lee, Shou‐Dong, Shang‐Jyh Hwang, Fa‐Yauh Lee, et al.. (2008). Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon α‐2b plus ribavirin. Alimentary Pharmacology & Therapeutics. 29(1). 46–54. 48 indexed citations

20.

Zhu, Haidong, et al.. (1999). [Origin and progress of myelodysplastic syndrome with hypoplasia].. PubMed. 38(6). 370–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact